While earlier studies suggested a possible modest increase in risk, more recent comprehensive analyses have found no significant association after adjusting for confounding factors such as obesity, diabetes duration, and concurrent medications
Weight loss typically begins in this phase, averaging 1 to 3 pounds per week for most patients, though individual results vary significantly based on starting weight, diet quality, and activity level
Aim for at least 8 glasses or 64 ounces of water daily
In this context, the data currently available on tirzepatide, showing its efficacy in glycemic control to the extent that a considerable percentage of patients achieve glucose levels indicative of diabetes remission [3, 59], as well as its high effectiveness in weight management, are promising regarding its future use in clinical practice